CANCER COMMUNICATIONS AND CONSULTANCY LIMITED

Accounts Submitted 27 Jun 2025

Confirmation Statement Submitted 6 Feb 2025

Net assets £4.07M £1.08M 2024 year on year

Total assets £0.00 £3.11M 2024 year on year

Total Liabilities £242.05K £124.17K 2024 year on year

Charges 1

1 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Office (Macclesfield)

The Ropewalks, Newton St, Macclesfield SK11 6QJ

Telephone

0156 575 4436

info@cancercom.co.uk

Website

cancercom.co.uk

Credit Report

Discover CANCER COMMUNICATIONS AND CONSULTANCY LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£194.28k

Increased by £117.91k (+154%)

Net Assets

£4.07M

Increased by £1.08M (+36%)

Total Liabilities

£242.05k

Increased by £124.17k (+105%)

Turnover

£1.84M

Increased by £4.26k (+0%)

Employees

Debt Ratio

N/A

Decreased by 4 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 6 resigned

Show resigned officers

						Status
Gabrielle Alison Silver	Director	British	England	52	15 Feb 2024	Active
James Maxwell	Director	British	United Kingdom	41	15 Feb 2024	Active

Shareholders

Shareholders (3)


Meridian Healthcomms Holdings Limited	45.0%	45	A Ordinary	6 Feb 2025
Meridian Healthcomms Holdings Limited	45.0%	45	B Ordinary	6 Feb 2025
Meridian Healthcomms Holdings Limited	10.0%	10	C Ordinary	6 Feb 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Meridian Healthcomms Holdings Limited

United Kingdom

Active

Notified 30 Nov 2020

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

Anne Rosemary Kinsella

Ceased 30 Nov 2020

Ceased

Laurence Spears Burt

Ceased 30 Nov 2020

Ceased

See All Controllers

Group Structure

MERIDIAN HEALTHCOMMS HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT HOLDINGS LIMITED united kingdom significant influence or control

SOVEREIGN CAPITAL PARTNERS LLP united kingdom

BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership

CANCER COMMUNICATIONS AND CONSULTANCY LIMITED Current Company

CANCER COMMUNICATIONS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

1 outstanding

Documents

Company Filings

Date	Category	Description	Document
27 Jun 2025	Accounts	Annual accounts made up to 2024-09-30	View(22 pages)
7 Feb 2025	Officers	Change to director Mr James Maxwell on 2025-02-06	View(2 pages)
6 Feb 2025	Confirmation Statement	Confirmation statement made on 2025-01-23 with updates	View(5 pages)
6 Feb 2025	Officers	Change to director Dr Gabrielle Alison Silver on 2025-02-06	View(2 pages)
6 Feb 2025	Persons With Significant Control	Change to Meridian Healthcomms Holdings Limited as a person with significant control on 2025-02-06	View(2 pages)